Outcome prediction with a social cognitive battery: a multicenter longitudinal study.


Journal

NPJ schizophrenia
ISSN: 2334-265X
Titre abrégé: NPJ Schizophr
Pays: United States
ID NLM: 101657919

Informations de publication

Date de publication:
26 May 2021
Historique:
received: 03 12 2020
accepted: 29 03 2021
entrez: 27 5 2021
pubmed: 28 5 2021
medline: 28 5 2021
Statut: epublish

Résumé

The interest in social cognition in schizophrenia is justified by the relationship between deficits in these skills and negative functional outcomes. Although assessment batteries have already been described, there is no consensus about which measures are useful in predicting patient functioning or quality of life (QoL). We investigated a set of five measures of recognition of facial emotions, theory of mind (ToM), and empathy in a cohort of 143 patients with schizophrenia or schizoaffective disorder at inclusion and, amongst whom 79 were reassessed 1 year later. The distribution was satisfactory for the TREF (Facial Emotion Recognition Task), V-SIR (Versailles-Situational Intention Reading), and QCAE (Questionnaire of Cognitive and Affective Empathy). Internal consistency was satisfactory for the TREF, V-SIR, V-Comics (Versailles Intention Attribution Task), and QCAE. Sensitivity to change was acceptable for the TREF. The TREF and V-SIR showed a cross-sectional relationship with functioning beyond the clinical symptoms of schizophrenia but not beyond neurocognition. Moreover, the TREF and V-SIR at inclusion could not predict functioning one year later, whereas most neurocognitive and clinical dimensions at inclusion could. Finally, only affective QCAE showed a significant cross-sectional, but not longitudinal, association with QoL. In conclusion, the TREF had satisfactory psychometric properties and showed a cross-sectional, but not longitudinal, association with objective outcome measures, thus appearing to be reliable in clinical practice and research. The V-SIR also showed promising psychometric properties, despite a possible weakness to detect change. However, these measures should be interpreted within the context of the good predictive power of the neurocognitive and clinical status on the outcome.

Identifiants

pubmed: 34039999
doi: 10.1038/s41537-021-00160-5
pii: 10.1038/s41537-021-00160-5
pmc: PMC8155046
doi:

Types de publication

Journal Article

Langues

eng

Pagination

30

Subventions

Organisme : Direction Générale de l'offre de Soins (DGOS)
ID : AOM11233
Organisme : Agence Nationale de la Recherche (French National Research Agency)
ID : ANR-11-IDEX-0004-02
Organisme : Agence Nationale de la Recherche (French National Research Agency)
ID : ANR-10-COHO-10-01

Références

Schizophr Bull. 2013 Nov;39(6):1211-8
pubmed: 24072806
Schizophr Bull. 2013 Jan;39(1):102-11
pubmed: 21765165
Psychol Med. 2012 Nov;42(11):2287-99
pubmed: 22475159
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Schizophr Res. 2013 Jul;147(2-3):275-80
pubmed: 23693066
Front Psychiatry. 2020 Jun 05;11:524
pubmed: 32581892
Neurosci Biobehav Rev. 2011 Jan;35(3):573-88
pubmed: 20620163
Schizophr Res. 2018 May;195:385-390
pubmed: 29056491
BMC Neurosci. 2010 Sep 16;11:118
pubmed: 20846444
Q J Exp Psychol (Hove). 2011 May;64(5):975-90
pubmed: 21161856
Schizophr Bull. 2006 Oct;32 Suppl 1:S44-63
pubmed: 16916889
Arch Gen Psychiatry. 2007 Oct;64(10):1115-22
pubmed: 17909123
Schizophr Res. 2011 Apr;127(1-3):157-62
pubmed: 21211943
Schizophr Res. 2018 Nov;201:105-112
pubmed: 29898819
Schizophr Res. 2018 Mar;193:51-57
pubmed: 28648914
Aust N Z J Psychiatry. 2008 Jun;42(6):496-504
pubmed: 18465376
Schizophr Res. 2012 May;137(1-3):246-50
pubmed: 22356801
Med Care. 2000 Sep;38(9 Suppl):II84-90
pubmed: 10982093
Schizophr Res. 2007 Feb;90(1-3):316-24
pubmed: 17141477
Qual Life Res. 2008 Dec;17(10):1247-56
pubmed: 18855124
Int J Ment Health Nurs. 2004 Dec;13(4):282-91
pubmed: 15660598
Psychiatry Res. 2008 Jul 15;160(1):55-62
pubmed: 18485488
J Clin Med. 2019 Aug 10;8(8):
pubmed: 31405155
Psychiatry Res. 2009 May 15;167(1-2):28-35
pubmed: 19346006
Schizophr Bull. 2011 Sep;37 Suppl 2:S41-54
pubmed: 21860046
Curr Med Res Opin. 2009 Feb;25(2):325-38
pubmed: 19192977
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 16;34(3):463-8
pubmed: 20109511
Psychiatry Res. 2014 May 30;216(3):325-32
pubmed: 24636245
J Psychiatr Res. 2018 Sep;104:65-71
pubmed: 29982084
Neurosci Biobehav Rev. 2019 Oct;105:212-219
pubmed: 31415864
Eur Arch Psychiatry Clin Neurosci. 2019 Aug;269(5):599-610
pubmed: 30963264
Psychiatry Res. 2008 Nov 30;161(2):213-24
pubmed: 18848731
J Pers Assess. 2011 Jan;93(1):84-95
pubmed: 21184334
Psychiatry Res. 2014 Sep 4;:
pubmed: 25412980
Encephale. 2015 Jun;41(3):251-9
pubmed: 25240938
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Feb;29(2):239-44
pubmed: 15694230
Front Psychiatry. 2013 May 06;4:30
pubmed: 23653606
Psychiatry Res. 1994 Jul;53(1):31-40
pubmed: 7991730
Schizophr Bull. 2013 Nov;39(6):1201-10
pubmed: 24072805
Schizophr Res. 2010 Aug;121(1-3):241-50
pubmed: 20541912
Schizophr Bull. 2018 Jun 6;44(4):737-748
pubmed: 28981848
J Nerv Ment Dis. 2008 Feb;196(2):95-9
pubmed: 18277216
Psychiatry Clin Neurosci. 2009 Aug;63(4):521-8
pubmed: 19531107
Cogn Neuropsychiatry. 2003 May;8(2):129-39
pubmed: 16571555
Nat Rev Neurosci. 2015 Oct;16(10):620-31
pubmed: 26373471
Psychiatry Res. 2014 Dec 15;220(1-2):51-7
pubmed: 25066964

Auteurs

Eric Brunet-Gouet (E)

FondaMental Foundation, Créteil, France. ebrunet@ch-versailles.fr.
Department of Adult Psychiatry, Centre Hospitalier de Versailles, Le Chesnay, France. ebrunet@ch-versailles.fr.
DisAP, DevPsy, CESP, Inserm 1018, University Paris Saclay, INSERM, Villejuif, France. ebrunet@ch-versailles.fr.

Capucine Decaix-Tisserand (C)

FondaMental Foundation, Créteil, France.
Department of Adult Psychiatry, Centre Hospitalier de Versailles, Le Chesnay, France.
DisAP, DevPsy, CESP, Inserm 1018, University Paris Saclay, INSERM, Villejuif, France.

Mathieu Urbach (M)

FondaMental Foundation, Créteil, France.
Department of Adult Psychiatry, Centre Hospitalier de Versailles, Le Chesnay, France.
DisAP, DevPsy, CESP, Inserm 1018, University Paris Saclay, INSERM, Villejuif, France.

Nadine Bazin (N)

FondaMental Foundation, Créteil, France.
Department of Adult Psychiatry, Centre Hospitalier de Versailles, Le Chesnay, France.
DisAP, DevPsy, CESP, Inserm 1018, University Paris Saclay, INSERM, Villejuif, France.

Bruno Aouizerate (B)

FondaMental Foundation, Créteil, France.
Department of Adult Psychiatry, Charles Perrens Hospital, Bordeaux, France.
Laboratory of Nutrition and Integrative Neurobiology (UMR INRA 1286), University of Bordeaux, Bordeaux, France.

Lore Brunel (L)

FondaMental Foundation, Créteil, France.
INSERM U955, Translational Psychiatry Team, Creteil, France.
Departement Medico-Universitaire de Psychiatrie et d'Addictologie (DMU ADAPT), Federation Hospitalo-Universitaire de Médecine de Precision (FHU IMPACT), AP-HP, HU Henri Mondor, Creteil, France.

Delphine Capdevielle (D)

FondaMental Foundation, Créteil, France.
University Department of Adult Psychiatry, Hospital La Colombière, CHU Montpellier, Montpellier, France.
INSERM, Univ Montpellier, Neuropsychiatry: Epidemiological and Clinical Research, Montpellier, France.
University of Montpellier, Montpellier, France.

Isabelle Chereau (I)

FondaMental Foundation, Créteil, France.
CHU Clermont-Ferrand, Service de Psychiatrie B, Université Clermont Auvergne, Clermont-Ferrand, France.

Caroline Dubertret (C)

FondaMental Foundation, Créteil, France.
AP-HP; Department of Psychiatry, Louis Mourier Hospital, Colombes, France.
Inserm UMR1266, Institute of Psychiatry and Neuroscience of Paris, University Paris Descartes, Paris, France.
Sorbonne Paris Cité, Faculté de Médecine, Université Paris Diderot, Paris, France.

Julien Dubreucq (J)

FondaMental Foundation, Créteil, France.
Psychosocial Rehabilitation Reference Centre, Alpes Isère Hospital, Grenoble, France.

Guillaume Fond (G)

FondaMental Foundation, Créteil, France.
La Conception Hospital, AP-HM, Aix-Marseille Univ., School of Medicine-La Timone Medical Campus, EA 3279: CEReSS-Health Service Research and Quality of Life Center, Marseille, France.

Christophe Lançon (C)

FondaMental Foundation, Créteil, France.
Ste Marguerite Hospital, AP-HM, Aix-Marseille Univ., School of Medicine-La Timone Medical Campus, EA 3279: CEReSS-Health Service Research and Quality of Life Center, Marseille, France.

Sylvain Leignier (S)

FondaMental Foundation, Créteil, France.
Psychosocial Rehabilitation Reference Centre, Alpes Isère Hospital, Grenoble, France.

Jasmina Mallet (J)

FondaMental Foundation, Créteil, France.
AP-HP; Department of Psychiatry, Louis Mourier Hospital, Colombes, France.
Inserm UMR1266, Institute of Psychiatry and Neuroscience of Paris, University Paris Descartes, Paris, France.
Sorbonne Paris Cité, Faculté de Médecine, Université Paris Diderot, Paris, France.

David Misdrahi (D)

FondaMental Foundation, Créteil, France.
Department of Adult Psychiatry, Charles Perrens Hospital, Bordeaux, France.

Sylvie Pires (S)

FondaMental Foundation, Créteil, France.
CHU Clermont-Ferrand, Service de Psychiatrie B, Université Clermont Auvergne, Clermont-Ferrand, France.

Priscille Schneider (P)

FondaMental Foundation, Créteil, France.
Department of Psychiatry, University Hospital of Strasbourg, Strasbourg, France.
University of Strasbourg, Strasbourg, France.
Inserm U1114, Strasbourg, France.

Franck Schurhoff (F)

FondaMental Foundation, Créteil, France.
INSERM U955, Translational Psychiatry Team, Creteil, France.
Departement Medico-Universitaire de Psychiatrie et d'Addictologie (DMU ADAPT), Federation Hospitalo-Universitaire de Médecine de Precision (FHU IMPACT), AP-HP, HU Henri Mondor, Creteil, France.

Hanan Yazbek (H)

FondaMental Foundation, Créteil, France.
University Department of Adult Psychiatry, Hospital La Colombière, CHU Montpellier, Montpellier, France.
INSERM, Univ Montpellier, Neuropsychiatry: Epidemiological and Clinical Research, Montpellier, France.
University of Montpellier, Montpellier, France.

Anna Zinetti-Bertschy (A)

FondaMental Foundation, Créteil, France.
Department of Psychiatry, University Hospital of Strasbourg, Strasbourg, France.
University of Strasbourg, Strasbourg, France.
Inserm U1114, Strasbourg, France.

Christine Passerieux (C)

FondaMental Foundation, Créteil, France.
Department of Adult Psychiatry, Centre Hospitalier de Versailles, Le Chesnay, France.
DisAP, DevPsy, CESP, Inserm 1018, University Paris Saclay, INSERM, Villejuif, France.

Paul Roux (P)

FondaMental Foundation, Créteil, France.
Department of Adult Psychiatry, Centre Hospitalier de Versailles, Le Chesnay, France.
DisAP, DevPsy, CESP, Inserm 1018, University Paris Saclay, INSERM, Villejuif, France.

Classifications MeSH